131 related articles for article (PubMed ID: 8301234)
1. Cholesterol and sphingomyelin syntheses are regulated independently in cultured human intestinal cells, CaCo-2: role of membrane cholesterol and sphingomyelin content.
Chen H; Born E; Mathur SN; Field FJ
J Lipid Res; 1993 Dec; 34(12):2159-67. PubMed ID: 8301234
[TBL] [Abstract][Full Text] [Related]
2. Plasma membrane sphingomyelin and the regulation of HMG-CoA reductase activity and cholesterol biosynthesis in cell cultures.
Gupta AK; Rudney H
J Lipid Res; 1991 Jan; 32(1):125-36. PubMed ID: 2010684
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxycholesterol stimulates sphingomyelin synthesis in Chinese hamster ovary cells.
Ridgway ND
J Lipid Res; 1995 Jun; 36(6):1345-58. PubMed ID: 7666011
[TBL] [Abstract][Full Text] [Related]
4. Effect of lovastatin on acyl-CoA: cholesterol O-acyltransferase (ACAT) activity and the basolateral-membrane secretion of newly synthesized lipids by CaCo-2 cells.
Kam NT; Albright E; Mathur S; Field FJ
Biochem J; 1990 Dec; 272(2):427-33. PubMed ID: 2268271
[TBL] [Abstract][Full Text] [Related]
5. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
Boogaard A; Griffioen M; Cohen LH
Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity does not affect the secretion rate of apolipoproteins B and AI by CaCo-2 cells.
Pau E; He Y; Lougheed M; Steinbrecher UP
Biochem Cell Biol; 1995; 73(1-2):81-90. PubMed ID: 7662319
[TBL] [Abstract][Full Text] [Related]
7. The rate of sphingomyelin synthesis de novo is influenced by the level of cholesterol in cultured human skin fibroblasts.
Leppimäki P; Kronqvist R; Slotte JP
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):285-91. PubMed ID: 9761725
[TBL] [Abstract][Full Text] [Related]
8. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells.
Hidaka Y; Hotta H; Nagata Y; Iwasawa Y; Horie M; Kamei T
J Biol Chem; 1991 Jul; 266(20):13171-7. PubMed ID: 1649182
[TBL] [Abstract][Full Text] [Related]
9. Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites.
Cohen LH; Griffioen M
Biochem J; 1988 Oct; 255(1):61-7. PubMed ID: 2848511
[TBL] [Abstract][Full Text] [Related]
10. Regulation of sterol regulatory element-binding proteins by cholesterol flux in CaCo-2 cells.
Field FJ; Born E; Murthy S; Mathur SN
J Lipid Res; 2001 Oct; 42(10):1687-98. PubMed ID: 11590226
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Peffley DM; Gayen AK
Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
[TBL] [Abstract][Full Text] [Related]
13. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis by oxylanosterols.
Panini SR; Sexton RC; Gupta AK; Parish EJ; Chitrakorn S; Rudney H
J Lipid Res; 1986 Nov; 27(11):1190-204. PubMed ID: 3559385
[TBL] [Abstract][Full Text] [Related]
14. Control of cholesterol biosynthesis in Schwann cells.
Fu Q; Goodrum JF; Hayes C; Hostettler JD; Toews AD; Morell P
J Neurochem; 1998 Aug; 71(2):549-55. PubMed ID: 9681444
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity.
Chen H; Born E; Mathur SN; Johlin FC; Field FJ
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):771-7. PubMed ID: 1417735
[TBL] [Abstract][Full Text] [Related]
16. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis in Syrian hamster C100 cells by mevinolin, 25-hydroxycholesterol, and mevalonate: the role of posttranscriptional control.
Peffley DM
Somat Cell Mol Genet; 1992 Jan; 18(1):19-32. PubMed ID: 1546367
[TBL] [Abstract][Full Text] [Related]
17. In vivo regulation of canine intestinal 3-hydroxy-3-methylglutaryl coenzyme A reductase by cholesterol, lipoprotein, and fatty acids.
Gebhard RL; Prigge WF
J Lipid Res; 1981 Sep; 22(7):1111-8. PubMed ID: 7299291
[TBL] [Abstract][Full Text] [Related]
18. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by oxysterol by-products of cholesterol biosynthesis. Possible mediators of low density lipoprotein action.
Panini SR; Sexton RC; Rudney H
J Biol Chem; 1984 Jun; 259(12):7767-71. PubMed ID: 6736025
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of sterol synthesis by the monoterpene perillyl alcohol is unaffected by competitive 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
Cerda SR; Wilkinson J; Branch SK; Broitman SA
Lipids; 1999 Jun; 34(6):605-15. PubMed ID: 10405975
[TBL] [Abstract][Full Text] [Related]
20. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE
J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
